Peripheral

Top Story

FDA: Paclitaxel device use requires risk-benefit discussion with patients

January 24, 2020
Meeting News

Medical therapy beneficial in PAD, but underprescribed

January 23, 2020
There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is reflected in guidelines but not followed nearly enough, a…

Top intervention news of 2019: ISCHEMIA trials, low-risk TAVR, paclitaxel debate and more

January 18, 2020
Healio and Cardiology Today compiled a list of the most-read cardiac and vascular intervention articles published in 2019. Readers were interested in results of trials…
In the JournalsPerspective

Meta-analysis: Paclitaxel-coated balloons may be harmful in below-the-knee lesions

January 15, 2020
A systematic review and study-level meta-analysis of randomized controlled trials of treatment of infrapopliteal arteries found that paclitaxel-coated balloons confer…
More Headlines »
The Take Home

The Take Home: TCT

Cardiology Today's Intervention, January/February 2019
The annual Transcatheter Cardiovascular Therapeutics Scientific Symposium, held Sept. 21 to 25 in San Diego, brought…
More »
Video
Meeting News

VIDEO: Paclitaxel, CLI epidemic among hottest topics at ISET

February 6, 2019
More »
Meeting News

Medical therapy beneficial in PAD, but underprescribed

January 23, 2020
There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is…
More »